Physiologically, FGF21 is considered a stress-induced hormone whose levels rise in metabolically compromised states, such as obesity (Zhang et al., 2008) and NASH (Barb et al., 2019). Here, FGF21 is linked to metabolic dysfunction-associated steatohepatitis.